Abreva and Hemady drug interactions - a phase IV clinical study of FDA data
We study 16,336 people who take Abreva or Hemady. There is no drug interaction reported.
The phase IV clinical study analyzes what interactions people who take Abreva and Hemady have. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Abreva?
Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,320 Abreva users for its effectiveness, alternative drugs and more.
What is Hemady?
Hemady has active ingredients of dexamethasone. eHealthMe is studying from 16 Hemady users for its effectiveness, alternative drugs and more.
Do you take Abreva and Hemady?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Alternative drugs to, pros and cons of the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on docosanol and dexamethasone (the active ingredients of Abreva and Hemady, respectively), and Abreva and Hemady (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Abreva and Hemady.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- L-Lysine and Muscle Aches - 41 seconds ago
- Coreg and Ankle Fracture - 45 seconds ago
- Coumadin and Glaucoma Aggravated - 58 seconds ago
- Latuda and Confusional State - a minute ago
- Azathioprine and Hyperhidrosis - a minute ago
- Lupron and Respiratory Depression - a minute ago
- Tretinoin and Oesophageal Hypomotility - a minute ago
- Luvox and Keratoconus - a minute ago
- Calcium Lactate and Infective Pulmonary Exacerbation Of Cystic Fibrosis - a minute ago
- Alcohol and Arrhythmias - a minute ago